Stewart Abbot, Chief Scientific Officer, Adicet Bio
Elsa Abranches, Group Leader, Section Of Stem Cell Biology, NIBSC/MHRA
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center
Nada Alaaeddine, Head Of The Regenerative And Inflammation Lab In The Faculty Of Medicine, Lebanese university
Aglaia Athanassiadou, Professor Emeritus, University of Patras
Frank Barry, Scientific Director, Regenerative Medicine Institute
Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)
Tim Bertram, Chief Executive Officer, ProKidney
Luc Boileau, Chief Executive Officer, INESSS
Daria Bou Dargham, Business development manager, Genethon
Philip J. Brooks, Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
Alex Butcher, Consultant, Next Phase Recruitment
Paul Butler, Sales Business Development Manager, Advanced Instruments
Didier Caizergues, Head of International Regulatory Affairs, Genethon
Heather Callahan, Director of Licensing, University of Colorado
Bradley Campbell, Chief Business Officer, Amicus Therapeutics Inc
Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica
Paul S Carter, Director, Head Vector Processing, Quell Therapeutics
Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics
Maria Cho, VP, Business Development, Dendreon Pharmaceuticals LLC
Angela Columbano, Head Of Business Development And Partnership, Genethon
Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics
Yemisi Corinaldi, Regulatory Strategy Leader, Spark Therapeutics UK Limited
Vicki Coutinho, VP Regulatory Affairs, GammaDelta Therapeutics
Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center
Derek Dashti, Founder And Chief Executive Officer, D and P Bioinnovations
Francesco Dazzi, Professor Of Regenerative And Hematological Medicine, King's College London
Michele de Guise, Scientific Vice-President, INESSS
Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine
Dominik Egger, Research Associate, University Of Natural Resources And Life Sciences Vienna
Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Marco Fadda, ATMP Solutions Manager, Comecer S.p.A.
Miguel Forte, Chief Executive Officer, Bone Therapeutics
Mike Fraser, Head of EMEA Region, Novartis Gene Therapies
Bobby Gaspar, CEO, Orchard Therapeutics
André Gerth, Chief Executive Officer, BioPlanta GmbH
Faruque Ghanchi, Consultant Ophthalmologist, Head, Bradford Ophthalmology Research Network (Born), Specialty Lead- Ophthalmology, Bradford Teaching Hospitals N.H.S. Foundation Trust
Paul Gissen, Professor of Metabolic Medicine, Head of Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health
Janet Glassford, Senior Quality Assessor, Medicines & Healthcare Products Regulatory Agency
Simon Goldman, Investment Director, Albion Capital
David Greenwald, Vice President Of Business Development, Deerfield Management
Jennifer Harbottle, Senior Scientist, R&D, Cell and Gene Therapy, Horizon Discovery Ltd
Hansjorg Hauser, Head of Department Gene Regulation and Differentiation, Helmholtz Centre for Infection Research GmbH
Christopher R Heery, Chief Medical Officer, Precision BioSciences
Amir Hefni, VP, Global Commercial Head, Cell & Gene, Novartis
Christoph Herwig, Professor Of Biochemical Engineering, Vienna University of Technology
Volker Huppert, Chief Development Officer, Glycostem Therapeutics BV
Dr Moshe Israeli, Medical Director, Rabin Medical Center
Lilian Jallow, Research Coordinator, Karolinska Institutet
Robert Jones, Vice President - Global Bioservices, Cryoport Systems
Troels Jordansen, Chief Executive Officer, Glycostem Therapeutics
Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma
Hans S Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.
Aisha Khan, Executive Director Of Lab Operations At The Interdisciplinary Stem Cell Institute, Miller School of Medicine University of Miami
Sven Kili, CEO, Antion Biosciences
Jarema (Jarko) Kochan, Head Of Biomarkers, Diagnostics And Assay Development, Turnstone Biologics
Sebastian Kress, Postdoctoral Scientist, Institute of Cell and Tissue Culture Technologies, BOKU
Stephen Lock, Senior Marketing and Market Development Manager, EMEAI, SCIEX
Tim Luker, Global Director, External Innovation, External Research And Development, Eli Lilly And Company
Rachel Manley, Head Of Global Outreach, Save the Cord Foundation
Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration
David Mazzo, Chief Executive Officer, Caladrius Biosciences
Janneke Meulenberg, Managing Director, MeiraGTx Netherlands B.V.
Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine
David Morrow, Senior Scientific Program Manager, EATRIS
Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Libby Naylor, Sales Account Manager, GenScript Biotech (Netherlands) B.V.
Charis Ober, Founder And Executive Director, Save the Cord Foundation
Daniel O'Mahony, Partner, Seroba Life Sciences
Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)
Dominic O'Regan, Business Development Consultant & Investor, New Mosaic
Sean Palecek, Director for Research, University of Wisconsin, Stem Cell and Regenerative Medicine Center
Ioannis Papantoniou, Assoc. Professor of Tissue Engineering and Biomanufacturing, Prometheus division of Skeletal Tissue Engineering, KU Leuven
Detlev Parow, Head Pharmaceutical Department, DAK-Gesundheit
Vivienne Parry, Head Of Engagement, Genomics England
David Pauza, Chief Science Officer, American Gene Technologies International Inc.
Avery Posey, Assistant Professor, University of Pennsylvania
Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London
Lior Raviv, Vice President ,Development & Operations, Pluristem Therapeutics
Albert Ribickas, BMT Laboratory Manager, Moffitt Cancer Center
Jessica Robinson, Project director, Terrapinn Ltd
Kate Rochlin, VP Operations & Innovation, in8bio
Mark Sawicki, Chief Executive Officer, Cryoport Systems
Dominic Schmidt, Partner, Syncona Investment Management Ltd
Martina Sebastian, Sales Manager, Univercells Technologies
Tamir Singer, Head of Commercial Development, NHS England
Owen Smith, Investment Director, 4BIO Capital
Devyn Smith, CEO, Arbor Biotechnologies
Joseph Stavas, Senior Vice President of Clinical Development, ProKidney
Kendal Studd, Scientific Application Specialist, Advanced Instruments Ltd
Mathias Svahn, Chief Executive Officer, NextCell Pharma
Magali Taiel, Medical Chief Officer, Gensight Biologics
Marina Tarunina, Research Director, Plasticell
Stefanos Theoharis, Chief Business Officer, Bone Therapeutics
Pamela Tranter, Translational Reserach Manager, University College London
Birgitte Volck, Non Executive Director, Soleno Therapeutics
Simon Waddington, Professor of Gene Therapy, UCL
Tom Wilton, Chief Business Officer, Carisma Therapeutics
Sara Wrobel, European Product Manager - Genomics, Bio-Techne
Lumeng Ye, Senior Scientist, R&D department, GenScript
Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon
Organiser
